Seach Medical Group Ltd (SEMG.TA)

ILA 313.8

(0.26%)

EBITDA Summary of Seach Medical Group Ltd

Seach Medical Group Ltd's latest annual EBITDA in 2023 was 1.29 Million ILS , down -86.07% from previous year.
Seach Medical Group Ltd's latest quarterly EBITDA in 2024 Q1 was 895 Thousand ILS , up 121.11% from previous quarter.
Seach Medical Group Ltd reported an annual EBITDA of 9.28 Million ILS in 2022, up 25.62% from previous year.
Seach Medical Group Ltd reported an annual EBITDA of 7.39 Million ILS in 2021, up 19.99% from previous year.
Seach Medical Group Ltd reported a quarterly EBITDA of N/A for 2023 FY, down -86.07% from previous quarter.
Seach Medical Group Ltd reported a quarterly EBITDA of 2.21 Million ILS for 2023 Q3, up 136.47% from previous quarter.

Annual EBITDA Chart of Seach Medical Group Ltd (2023 - 2015)

Historical Annual EBITDA of Seach Medical Group Ltd (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	1.29 Million ILS	-86.07%
2022	9.28 Million ILS	25.62%
2021	7.39 Million ILS	19.99%
2020	6.15 Million ILS	13.76%
2019	5.41 Million ILS	-43.0%
2018	9.49 Million ILS	164.52%
2017	3.59 Million ILS	51.33%
2016	2.37 Million ILS	146.31%
2015	-5.12 Million ILA	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	895 Thousand ILS	121.11%
2023 FY	- ILS	-86.07%
2023 Q3	2.21 Million ILS	136.47%
2023 Q1	2.38 Million ILS	326.26%
2023 Q2	935 Thousand ILS	-60.83%
2023 Q4	-4.24 Million ILS	-291.77%
2022 Q2	5.96 Million ILS	128.48%
2022 Q1	2.61 Million ILS	-28.65%
2022 FY	- ILS	25.62%
2022 Q4	-1.05 Million ILS	-154.63%
2022 Q3	1.93 Million ILS	-67.64%
2021 Q3	108 Thousand ILS	-94.07%
2021 Q4	3.66 Million ILS	3289.81%
2021 Q1	1.79 Million ILS	126.2%
2021 Q2	1.82 Million ILS	1.28%
2021 FY	- ILS	19.99%
2020 FY	- ILS	13.76%
2020 Q4	-6.86 Million ILS	-361.13%
2020 Q3	2.62 Million ILS	-57.6%
2020 Q2	6.19 Million ILS	47.7%
2020 Q1	4.19 Million ILS	564.05%
2019 FY	- ILS	-43.0%
2019 Q2	1.49 Million ILS	-31.84%
2019 Q4	-904 Thousand ILS	-134.22%
2019 Q1	2.18 Million ILS	0.0%
2019 Q3	2.64 Million ILS	77.32%
2018 Q1	887 Thousand ILS	0.0%
2018 FY	- ILS	164.52%
2017 FY	- ILS	51.33%
2016 FY	- ILS	146.31%
2015 FY	- ILA	0.0%

Peer EBITDA Comparison of Seach Medical Group Ltd

Name	EBITDA	EBITDA Difference
Cannabotech LTD	-14.81 Million ILA	108.731%